Related Experiment Videos
Molecular basis of cholesterol homeostasis: lessons from Tangier disease and ABCA1
1Department of Medicine, Box 356426, University of Washington, Seattle, WA 98195-6426, USA. joram@u.washington.edu
Insights
High-density lipoproteins (HDL) transport cholesterol for removal. ABCA1 protein facilitates this process, and its dysfunction causes cholesterol buildup and cardiovascular disease, making it a therapeutic target.
Area of Science:
- Biochemistry
- Cardiovascular Science
- Molecular Biology
Background:
- High-density lipoproteins (HDL) are crucial for reverse cholesterol transport, moving cholesterol from tissues to the liver.
- Cardiovascular disease is associated with cholesterol-laden macrophages and low HDL levels.
- ATP-binding cassette transporter A1 (ABCA1) is a cell-membrane protein essential for cholesterol efflux into the HDL pathway.
Purpose of the Study:
- To investigate the role of ABCA1 in cholesterol metabolism and HDL transport.
- To highlight ABCA1 as a potential therapeutic target for cardiovascular disease.
Main Methods:
- The study focuses on the function of the ABCA1 protein in cellular cholesterol transport.
- Analysis of genetic mutations in ABCA1 and their link to Tangier disease and atherosclerosis.
Main Results:
- Mutations in ABCA1 lead to Tangier disease, characterized by severe HDL deficiency.
- This deficiency results in cholesterol accumulation within tissue macrophages and increased atherosclerosis.
- ABCA1 facilitates cholesterol removal from macrophages, thereby increasing plasma HDL levels.
Conclusions:
- ABCA1 plays a critical role in regulating cellular cholesterol levels and HDL metabolism.
- Targeting ABCA1 presents a promising therapeutic strategy for mitigating cardiovascular disease by reducing macrophage cholesterol and increasing HDL.
- Understanding ABCA1 function is key to developing novel treatments for atherosclerosis and related conditions.
Abstract:
High-density lipoproteins (HDLs) play a role in transporting cholesterol from peripheral tissues to the liver for elimination from the body. Two hallmarks of cardiovascular disease are the presence of sterol-laden macrophages in the artery wall and reduced plasma HDL levels. A cell-membrane protein called ABCA1 mediates the secretion of excess cholesterol from cells into the HDL metabolic pathway. Mutations in ABCA1 cause Tangier disease, a severe HDL deficiency syndrome characterized by accumulation of cholesterol in tissue macrophages and prevalent atherosclerosis. Because of its ability to deplete macrophages of cholesterol and to raise plasma HDL levels, ABCA1 has become a promising therapeutic target for preventing cardiovascular disease.